Frequency and Type of Epidermal Growth Factor Receptor Mutations in Moroccan Patients with Lung Adenocarcinoma

Autor: Errihani, Hassan, Inrhaoun, Hanane, Boukir, Anouar, Kettani, Fouad, Gamra, Lamia, Mestari, Amina, Jabri, Lamia, Bensouda, Youssef, Mrabti, Hind, Elghissassi, Ibrahim

Publikováno v: In Journal of Thoracic Oncology September 2013 8(9):1212-1214

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma.

Autor: Elghissassi, Ibrahim, Inrhaoun, Hanane, Boukir, Anwar, Kettani, Fouad, Gamra, Lamia, Mestari, Amina, Jabri, Lamia, Bensouda, Youssef, Mrabti, Hind, Errihani, Hassan

Publikováno v: ISRN Otolaryngology; 2014, p1-4, 4p

Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer.

Autor: Lemine Sow M; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., El Yacoubi H; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Moukafih B; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Balde S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Akimana G; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Najem S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., El Khoyaali S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Abahssain H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Chaibi A; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Zeb Khan S; Department of Clinical Oncology, BINOR Cancer Hospital, Bannu, Pakistan., Trapani D; Department of Oncology and Hematology, University of Milan.; Division of New Drug Development, European Institute of Oncology, Milan, Italy., Benzekri A; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Ghaouti M; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Gamra L; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Mestari A; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Kettani F; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Rahali Y; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Mrabti H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Elghissassi I; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Errihani H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.

Publikováno v: Tumori [Tumori] 2021 Aug; Vol. 107 (4), pp. 335-340. Date of Electronic Publication: 2020 Oct 20.